Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI

$11.19 B
Marketcap
$54.30
Share price
Country
$1.51
Change (1 day)
$57.12
Year High
$45.73
Year Low

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

marketcap

P/E ratio for Recordati Industria Chimica e Farmaceutica S.p.A. (REC.MI)

P/E ratio as of 2023: 25.89

According to Recordati Industria Chimica e Farmaceutica S.p.A.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.89. At the end of 2022 the company had a P/E ratio of 25.51.

P/E ratio history for Recordati Industria Chimica e Farmaceutica S.p.A. from 2003 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 25.89
2022 25.51
2021 30.16
2020 26.27
2019 20.88
2018 19.64
2017 26.74
2016 23.37
2015 24.88
2014 16.23
2013 15.77
2012 11.73
2011 9.57
2010 12.89
2009 9.28
2008 7.58
2007 14.62
2006 15.62
2005 17.92
2004 16.20
2003 31.88